Global Nanobiotechnology Market size was valued at USD 32.18 Bn in 2022 and is expected to reach USD 70.26 Bn by 2029, at a CAGR of 11.8 %.
OverviewNanobiotechnology is the combination of nanotechnology and the biotechnology field and the study of biological systems at the nanoscale level, typically involving molecules and small particles. Nanobiology and bionanotechnology are other names that are used interchangeably with nanobiotechnology. It involves the application of nanomaterials, nanodevices, and nanoscale techniques to understand, interact with, and control biological processes, leading to a wide range of practical applications across various industries. These sectors are medicine & healthcare, biomedical research institutes, agriculture & food industry, energy & environment companies, IT and others. The increasing use and application of Nanobiotechnology is a key driver for Nanobiotechnology Market growth. North Carolina is a global leader in nanobiotechnology, with universities and industry focused on nanoscience research and applications. Nanobiotechnology is gathering substantial investment from businesses and governments globally. In the healthcare sector, nanobiotechnology is transforming the way diseases are diagnosed and treated. For instance, nanoparticles are being used to deliver drugs directly to cancer cells, thereby minimizing the side effects associated with traditional chemotherapy. This targeted approach to treatment is not only improving patient outcomes but also opening up new markets for pharmaceutical companies. Also, nanobiotechnology is enabling the development of rapid diagnostic tools that detect diseases at their earliest stages, thus facilitating timely intervention and reducing healthcare costs. Pfizer, one of the world's leading pharmaceutical companies, has invested in nanobiotechnology research and startups to explore innovative drug delivery methods and enhance therapeutic outcomes. Key developments include collaborations with nanotechnology companies to create targeted drug delivery systems for cancer treatment and vaccine development.
Nanobiotechnology Market SnapshotTo know about the Research Methodology :- Request Free Sample Report
Nanobiotechnology Market Dynamics1. Key Drivers for the Market Growth: Advancements in Nanomaterials and Nanofabrication Techniques to Boost the Market The continuous advancements in nanomaterials and nanofabrication techniques are expected to drive the global Nanobiotechnology Market. Scientists and engineers have made remarkable progress in designing and synthesizing nanoscale materials with unique properties and functionalities. For example, there is a wide variety of nanostructured materials with different dimensions which range from zero-dimensional (0D) nanoparticles, one-dimensional (1D) nanorods and nanowires, two-dimensional (2D) nanosheets and films, three-dimensional (3D) polycrystals and ultra-nanostructures, and nanoscaffolds. These advancements enable the development of more efficient and targeted drug delivery systems, nanosensors, and other nanobiotechnology-based applications. With improved nanomaterials, researchers are expected to explore novel approaches for diagnosing and treating diseases and are expected to increase the market size and demand. U.S. investments and competitiveness in nanotechnology R&D and challenges to U.S. competitiveness in nanomanufacturing. DARPA invests in high-risk, high-reward research projects, including nanotechnology initiatives, to drive technological breakthroughs that have potential military applications. The NNI fosters collaboration among agencies like the National Science Foundation (NSF), the National Institutes of Health (NIH), the Department of Energy (DOE), and the National Aeronautics and Space Administration (NASA). It provides funding for various research projects and initiatives in nanomaterials, nanofabrication, and other nanotechnology-related areas. Growing Prevalence of Chronic Diseases to Drive the Market Growth The increasing prevalence of chronic diseases across the world including cancer, diabetes, and cardiovascular disorders, is a major growth driver for the Nanobiotechnology Market. Nanobiotechnology provides better solutions for addressing issues regarding traditional treatments for these conditions. Nanoparticle-based drug delivery systems, for instance, enable targeted therapy, reducing side effects and improving patient outcomes. As the global burden of chronic diseases continues to rise, the demand for innovative nanobiotechnology solutions. Academic institutions, private companies and governments of various regions are heavily invested in R & D nanobiotechnology field. This is expected to help with technological advancements, new discoveries, and increased commercialization of nanobiotechnology-based products. These factors can make remarkable growth in the forecast period and the report provides an in-depth explanation with a strong research basis. In 2021, approximately 130 million Americans (45% of the population) had chronic conditions and 61 million (21% of the population) had multiple chronic conditions.
Prevalence of Chronic Diseases in US Share, by Age Group, (in %)Precision medicine, which tailors medical treatment to an individual's unique characteristics, is gaining prominence in the healthcare industry. The ability of nanobiotechnology to deliver drugs directly to the affected tissues or cells, along with its potential to modulate genes or immune responses, is driving the demand for personalized therapies. This focus on precision medicine is expected to be a major growth driver for the Nanobiotechnology Market. 2. Restrain Factors for the Market: Nanobiotechnology use of nanoscale materials, which have unique properties and potential risks. As a result, regulatory agencies have been careful in approving and commercializing nanobiotechnology products. Safety concerns regarding the toxicity and long-term effects of nanomaterials on human health and the environment are expected to increased scrutiny and stringent regulations. Thus, these factors are expected to restrain the Nanobiotechnology Market growth over the forecast period. Also, the ethical implications of gene editing, the privacy of personal genomic data, and equitable access to nanobiotechnology-based healthcare raise ethical debates and public apprehensions are expected to pose a challenge to the industry’s growth. 3. Major Opportunities and Trends of Nanobiotechnology Market a. Nano-Diagnostics and Imaging b. Advancements in Nanosensors c. Gene and Cell Therapies d. Nano-Enabled Agriculture and Food Industry e. Convergence with Artificial Intelligence (AI) and Machine Learning (ML) f. Nanotechnology in Energy Solutions Exploring the Impact of Nanobiotechnology on the Global Business Landscape The rise of nanobiotechnology also presents significant challenges for Nanobiotechnology Market growth. For instance, the development and commercialization of nanotech products require substantial investment in research and development, which is a barrier for small and medium-sized enterprises. The regulatory landscape for nanotech products is still evolving, creating uncertainty for businesses. There are ethical and societal concerns about the potential impacts of nanobiotechnology, which businesses need to address to maintain public trust and acceptance. The biomedical community has at best casual familiarity with recent advancements in nanotechnology. However, the nanotechnology community has potential applications for its newly developed tools and it is a major challenge in biological science.
Nanobiotechnology Market Segment AnalysisThe Nanobiotechnology Market report provides a segment analysis by type, application and region. Based on region market is analyzed into major five regions such as North America, APAC, Europe, South America and MEA. By Type: Based on type, the 0--10 nm nanobiotechnology segment held the largest Nanobiotechnology Market segment in 2022. It is the application of nanotechnology to biomedical research and healthcare. These nanoparticles have various uses as a treatment including drug delivery, cancer treatment, diagnostics, antibacterial applications and several others. For example, in drug delivery, nanobiotechnology allows the targeted delivery of drugs to specific cells or tissues in the body. Nanoscale drug carriers, such as liposomes or nanoparticles, can be designed to release therapeutic agents at the desired location, improving drug effectiveness and reducing side effects. By Application: Based on applications, the pharmaceutical segment held a major Nanobiotechnology Market share in 2022. It involves the application of nanoscale materials, devices, and techniques in the development and delivery of pharmaceutical products. This segment has the potential to revolutionize drug discovery, delivery, and therapeutic efficacy, leading to more targeted and personalized treatments for various diseases. The report provides these factors are how to affect market growth in detail.
Global Nanobiotechnology Market Share, by Application(%) in 2022However, Medical devices segments are expected to grow at a significant CAGR during the forecast period owing to increasing R&D activities by various companies for the development of innovative products using nanoshells or nanoparticles for diagnosis & treatment options in several healthcare areas such as cardiology, oncology & cancer research among others.
Nanobiotechnology Market Regional InsightNorth America dominated the largest Nanobiotechnology Market share in 2022 with 45% and is expected to grow at a CAGR during the forecast period. Well-established regulatory framework provided a conducive environment for the growth of nanobiotechnology. Regulatory agencies in the United States, such as the FDA, worked closely with industry and researchers to ensure the safety and efficacy of nanotech products. Also, the regional market growth is driven by industry collaboration and strong government support. The United States and Canada are at the forefront of nanobiotechnology developments, with numerous academic institutions, research centres, and biotechnology companies driving the progress. Merck KGaA, Ablynx, Johnson & Johnson, Abbott Laboratories, and Novartis AG are some major key players in the region. The Nanobiotechnology industry is competitive, with both established players and stratus leadership positions. Large pharmaceutical companies invested in nanobiotechnology startups and research to expand their product portfolios and stay ahead in the market. Nanomedicine and drug delivery are particularly prominent areas, with advanced clinical trials for cancer therapies and personalized medicine. The region's strong regulatory environment and access to funding have paved the way for significant advancements in the field. Europe market held the second largest Nanobiotechnology Market share in 2022. The high demand for technologically improved products and well-developed R and D facilities are primary factors for regional market growth. Germany and UK market dominated the largest regional market share. Asia Pacific Nanobiotechnology Market is expected to grow at a significant CAGR over the forecast period. The growing focus on research and affordable healthcare solutions is a key driver which is expected to boost market growth. The increasing biotechnology industry, government investments and initiatives, cancer research and targeted therapies, agriculture and environmental applications, and nanotechnology in electronics and materials are some other factors that are expected to drive regional market growth.
Global Market Share of Nanobiotechnology in 2022, by Region (%)Competitive Landscape The Nanobiotechnology Market involved various companies, research institutions, and universities. Leading players focus on extensive research and development to drive innovation in nanomedicines, nanosensors, and therapeutic applications. They actively engage in strategic partnerships and collaborations with academic institutions and healthcare providers to accelerate product development and commercialization. Market expansion efforts involve establishing a global presence, targeting emerging economies, and obtaining regulatory approvals. Key developments include frequent product launches, mergers, acquisitions, securing funding, and protecting intellectual property. The competitive landscape is characterized by a dynamic interplay of innovation, strategic alliances, and efforts to capitalize on diverse applications across healthcare, agriculture, energy, and the environment.
Nanobiotechnology Market Scope: Inquire Before Buying
Global Nanobiotechnology Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 32.18 Bn. Forecast Period 2023 to 2029 CAGR: 11.8% Market Size in 2029: US $ 70.26 Bn. Segments Covered: by Type 0-10 Nm 10-100 Nm by Therapeutics Dental Therapies 2Cardiac Therapies Orthopaedic Therapies Drug Delivery Applications Gene Delivery Cell/Gene Therapy Liposomes Other by Application Pharmaceuticals Medical Devices Medical Research Food and Agriculture
Nanobiotechnology Market, by RegionNorth America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America) Nanobiotechnology Key Players in North America 1. Nami Therapeutics (US) 2. Celgene Corporation (US) 3. Nanophase Technologies Corporation (US) 4. Sigma-Aldrich (US) 5. KGaA, Ablynx (US) 6. Johnson & Johnson(US) 7. Abbott Laboratories(US) 8. Novartis AG(US) Nanobiotechnology Manufacturers in Europe 1. Ablynx (Belgium) 2. SkyePharma Pharmaceuticals (France) 3. Nano Bridging Molecules SA (Switzerland) 4. XanTecbioanalytics GmbH (Germany) 5. Nanobiotix(France) Nanobiotechnology Leading Players in Asia Pacific 1. National University of Singapore (NUS) (Singapore) 2. Chinese Academy of Sciences (CAS) (China) 3. National Institute of Advanced Industrial Science and Technology (AIST) (Japan) 4. Indian Institute of Science (IISc) (India) 5. Korea Advanced Institute of Science and Technology (KAIST) (South Korea) 6. Riken Institute (Japan)
Frequently Asked Questions:1] What is the growth rate of the Global Nanobiotechnology Market? Ans. The Global Nanobiotechnology Market is growing at a significant rate of 11.8 % during the forecast period. 2] Which region is expected to dominate the Global Nanobiotechnology Market? Ans. North America region is expected to hold the Nanobiotechnology Market growth potential during the forecast period. 3] What is the expected Global Nanobiotechnology Market size by 2029? Ans. The Nanobiotechnology Market size is expected to reach USD 70.26 Bn by 2029. 4] Which are the top players in the Global Nanobiotechnology Market? Ans. The top player of the Nanobiotechnology key player Nami Therapeutics, Celgene Corporation and others. 5] What are the factors driving the Global Nanobiotechnology Market growth? Ans. The growing R and D investment from major players is a key driver for market growth.
1. Nanobiotechnology Market: Research Methodology 2. Nanobiotechnology Market: Executive Summary 3. Nanobiotechnology Market: Competitive Landscape 3.1. MMR Competition Matrix 3.2. Competitive Landscape 3.3. Key Players Benchmarking 3.4. Market Structure 3.4.1. Market Leaders 3.4.2. Market Followers 3.4.3. Emerging Players 3.5. Consolidation of the Market 4. Nanobiotechnology Market: Dynamics 4.1. Market Trends by Region 4.1.1. North America 4.1.2. Europe 4.1.3. Asia Pacific 4.1.4. Middle East and Africa 4.1.5. South America 4.2. Market Drivers by Region 4.2.1. North America 4.2.2. Europe 4.2.3. Asia Pacific 4.2.4. Middle East and Africa 4.2.5. South America 4.3. Market Restraints 4.4. Market Opportunities 4.5. Market Challenges 4.6. PORTER’s Five Forces Analysis 4.7. PESTLE Analysis 4.8. Value Chain Analysis 4.9. Regulatory Landscape by Region 4.9.1. North America 4.9.2. Europe 4.9.3. Asia Pacific 4.9.4. Middle East and Africa 4.9.5. South America 5. Nanobiotechnology Market Size and Forecast by Segments (by Value USD and Volume units) 5.1. Nanobiotechnology Market Size and Forecast, by Type (2022-2029) 5.1.1. 0-10 Nm 5.1.2. 10-100 Nm 5.2. Nanobiotechnology Market Size and Forecast, by Therapeutics (2022-2029) 5.2.1. Dental Therapies 5.2.2. Cardiac Therapies 5.2.3. Orthopaedic Therapies 5.2.4. Drug Delivery Applications 5.2.5. Gene Delivery 5.2.6. Cell/Gene Therapy 5.2.7. Liposomes 5.2.8. Other 5.3. Nanobiotechnology Market Size and Forecast, By Application (2022-2029) 5.3.1. Pharmaceuticals 5.3.2. Medical Devices 5.3.3. Medical Research 5.3.4. Food and Agriculture 5.4. Nanobiotechnology Market Size and Forecast, by Region (2022-2029) 5.4.1. North America 5.4.2. Europe 5.4.3. Asia Pacific 5.4.4. Middle East and Africa 5.4.5. South America 6. North America Nanobiotechnology Market Size and Forecast (by Value USD and Volume units) 6.1. North America Nanobiotechnology Market Size and Forecast, by Type (2022-2029) 6.1.1. 0-10 Nm 6.1.2. 10-100 Nm 6.2. North America Nanobiotechnology Market Size and Forecast, by Therapeutics (2022-2029) 6.2.1. Dental Therapies 6.2.2. Cardiac Therapies 6.2.3. Orthopaedic Therapies 6.2.4. Drug Delivery Applications 6.2.5. Gene Delivery 6.2.6. Cell/Gene Therapy 6.2.7. Liposomes 6.2.8. Other 6.3. North America Nanobiotechnology Market Size and Forecast, By Application (2022-2029) 6.3.1. Pharmaceuticals 6.3.2. Medical Devices 6.3.3. Medical Research 6.3.4. Food and Agriculture 6.4. North America Nanobiotechnology Market Size and Forecast, by Country (2022-2029) 6.4.1. United States 6.4.2. Canada 6.4.3. Mexico 7. Europe Nanobiotechnology Market Size and Forecast (by Value USD and Volume units) 7.1. Europe Nanobiotechnology Market Size and Forecast, by Type (2022-2029) 7.1.1. 0-10 Nm 7.1.2. 10-100 Nm 7.2. Europe Nanobiotechnology Market Size and Forecast, by Therapeutics (2022-2029) 7.2.1. Dental Therapies 7.2.2. Cardiac Therapies 7.2.3. Orthopaedic Therapies 7.2.4. Drug Delivery Applications 7.2.5. Gene Delivery 7.2.6. Cell/Gene Therapy 7.2.7. Liposomes 7.2.8. Other 7.3. Europe Nanobiotechnology Market Size and Forecast, By Application (2022-2029) 7.3.1. Pharmaceuticals 7.3.2. Medical Devices 7.3.3. Medical Research 7.3.4. Food and Agriculture 7.4. Europe Nanobiotechnology Market Size and Forecast, by Country (2022-2029) 7.4.1. UK 7.4.2. France 7.4.3. Germany 7.4.4. Italy 7.4.5. Spain 7.4.6. Sweden 7.4.7. Austria 7.4.8. Rest of Europe 8. Asia Pacific Nanobiotechnology Market Size and Forecast (by Value USD and Volume units) 8.1. Asia Pacific Nanobiotechnology Market Size and Forecast, by Type (2022-2029) 8.1.1. 0-10 Nm 8.1.2. 10-100 Nm 8.2. Asia Pacific Nanobiotechnology Market Size and Forecast, by Therapeutics (2022-2029) 8.2.1. Dental Therapies 8.2.2. Cardiac Therapies 8.2.3. Orthopaedic Therapies 8.2.4. Drug Delivery Applications 8.2.5. Gene Delivery 8.2.6. Cell/Gene Therapy 8.2.7. Liposomes 8.2.8. Other 8.3. Asia Pacific Nanobiotechnology Market Size and Forecast, By Application (2022-2029) 8.3.1. Pharmaceuticals 8.3.2. Medical Devices 8.3.3. Medical Research 8.3.4. Food and Agriculture 8.4. Asia Pacific Nanobiotechnology Market Size and Forecast, by Country (2022-2029) 8.4.1. China 8.4.2. S Korea 8.4.3. Japan 8.4.4. India 8.4.5. Australia 8.4.6. Indonesia 8.4.7. Malaysia 8.4.8. Vietnam 8.4.9. Taiwan 8.4.10. Bangladesh 8.4.11. Pakistan 8.4.12. Rest of Asia Pacific 9. Middle East and Africa Nanobiotechnology Market Size and Forecast (by Value USD and Volume units) 9.1. Middle East and Africa Nanobiotechnology Market Size and Forecast, by Type (2022-2029) 9.1.1. 0-10 Nm 9.1.2. 10-100 Nm 9.2. Middle East and Africa Nanobiotechnology Market Size and Forecast, by Therapeutics (2022-2029) 9.2.1. Dental Therapies 9.2.2. Cardiac Therapies 9.2.3. Orthopaedic Therapies 9.2.4. Drug Delivery Applications 9.2.5. Gene Delivery 9.2.6. Cell/Gene Therapy 9.2.7. Liposomes 9.2.8. Other 9.3. Middle East and Africa Nanobiotechnology Market Size and Forecast, By Application (2022-2029) 9.3.1. Pharmaceuticals 9.3.2. Medical Devices 9.3.3. Medical Research 9.3.4. Food and Agriculture 9.4. Middle East and Africa Nanobiotechnology Market Size and Forecast, by Country (2022-2029) 9.4.1. South Africa 9.4.2. GCC 9.4.3. Egypt 9.4.4. Nigeria 9.4.5. Rest of ME&A 10. South America Nanobiotechnology Market Size and Forecast (by Value USD and Volume units) 10.1. South America Nanobiotechnology Market Size and Forecast, by Type (2022-2029) 10.2. 0-10 Nm 10.3. 10-100 Nm South America Nanobiotechnology Market Size and Forecast, by Therapeutics (2022-2029) 10.3.1. Dental Therapies 10.3.2. Cardiac Therapies 10.3.3. Orthopaedic Therapies 10.3.4. Drug Delivery Applications 10.3.5. Gene Delivery 10.3.6. Cell/Gene Therapy 10.3.7. Liposomes 10.3.8. Other 10.4. South America Nanobiotechnology Market Size and Forecast, By Application (2022-2029) 10.4.1. Pharmaceuticals 10.4.2. Medical Devices 10.4.3. Medical Research 10.4.4. Food and Agriculture 10.5. South America Nanobiotechnology Market Size and Forecast, by Country (2022-2029) 10.5.1. Brazil 10.5.2. Argentina 10.5.3. Rest of South America 11. Company Profile: Key players 11.1. Nami Therapeutics (US) 11.1.1. Company Overview 11.1.2. Financial Overview 11.1.3. Business Portfolio 11.1.4. SWOT Analysis 11.1.5. Business Strategy 11.1.6. Recent Developments 11.2. Celgene Corporation (US) 11.3. Nanophase Technologies Corporation (US) 11.4. Sigma-Aldrich (US) 11.5. KGaA, Ablynx (US) 11.6. Johnson & Johnson(US) 11.7. Abbott Laboratories(US) 11.8. Novartis AG(US) 11.9. Ablynx (Belgium) 11.10. SkyePharma Pharmaceuticals (France) 11.11. Nano Bridging Molecules SA (Switzerland) 11.12. XanTecbioanalytics GmbH (Germany) 11.13. Nanobiotix(France) 11.14. National University of Singapore (NUS) (Singapore) 11.15. Chinese Academy of Sciences (CAS) (China) 11.16. National Institute of Advanced Industrial Science and Technology (AIST) (Japan) 11.17. Indian Institute of Science (IISc) (India) 11.18. Korea Advanced Institute of Science and Technology (KAIST) (South Korea) 11.19. Riken Institute (Japan) 12. Key Findings 13. Industry Recommendation